ABSTRACT: Leishmaniasis, a zoonosis of worldwide distribution, presents a significant impact on immunosupressed patients. This study aimed to evaluate Leishmania chagasi infection in BALB/c mice immunosuppressed with dexamethasone. Spleen cells stimulated or not with L. chagasi were cultured for cytokine quantification (IFN-γ, IL-2, IL-4 and IL-10) by sandwich ELISA. Parasite loads in the spleen and liver were determined by means of culture microtitration. Immunosuppressed groups showed statistically lower spleen weight and CD4-cell percentage in blood on the day of infection and produced Th1 and Th2 cytokines on other days of the study. The other infected groups, weather immunosupressed or not, also produced Th1 and Th2 cytokines. Parasite loads in the spleen and liver were not statistically different among the groups. It was concluded that L. chagasi infection was not affected by dexamethasone-induced immunosuppression, probably due the reversible effect of the treatment.
INTRODUCTION

Leishmaniasis is caused by trypanosomatidae protozoans of the genus Leishmania.
Diseases caused by these agents are severe and distributed worldwide, with incidence growing by two million cases a year and 350 million individuals at risk of infection in 88 countries (1) . Ninety percent of visceral leishmaniasis cases occur in India, Bangladesh, Nepal, Sudan and Brazil (2) .
Leishmania may cause cutaneous or visceral diseases and are important pathogens for immunocompromised hosts (3) . Co-infection with HIV and Leishmania has been reported in more than 25 countries, mainly in the Mediterranean region and, to a lesser extent, in Equatorial Africa, Asia and South America (4) (5) (6) (7) . Despite the innumerable studies on human and canine visceral leishmaniasis, many questions have yet to be answered (8) 
MATERIALS AND METHODS
This study was approved by the Ethics Committee of the Veterinary Medicine and
Animal Husbandry School, UNESP, São Paulo state, Brazil.
Animals
Eighty male, 5 week-old, BALB/c mice -from the Multidisciplinary Center for Biological Investigation (CEMIB) at State University of Campinas (UNICAMP), São Paulo state, Brazil -were used. Animals were kept in polypropylene boxes, fed commercial pelleted feed and had free access to water. Boxes were placed in an on day 0 and Group IV -animals immunosuppressed until day 0 and infected on day 0. Groups II and IV were immunosuppressed with 6.65 mg/kg dexamethasone sodium phosphate (Decadron®, Aché Laboratórios Farmacêuticos, Brazil) once a day by the intraperitoneal route, for 22 days (9) . Groups I and III were inoculated with water by injection using the same route and frequency as in the immunosuppression protocol. On day 0, immunosuppression was withdrawn in groups II and IV, and groups III and IV were infected.
Four animals of each group were euthanized on days 0, 3, 7, 14 and 21. The spleen was removed and weighed; spleen cells were cultured, and parasite loads of spleen and liver were determined for each animal.
Parasite Strain and Infection Protocol
Amastigote forms of Leishmania chagasi strain M6445 were used. Strains were 
Flow Cytometry
On day 0, blood samples of immunosuppressed (II and IV) and non- 
Parasite Load
Parasite load was quantified by means of culture microtitration (9) . Spleen and liver fragments were weighed and then macerated with 4 mL of Schneider drosophila medium, supplemented with 20% inactivated bovine fetal serum, 10,000 UI/mL penicillin and 10 mg/mL streptomycin (Cultilab, Brazil). Microtitration plates were prepared under sterile conditions and each sample was analyzed in quadruplicate.
The macerate was submitted to serial fourfold dilutions, from 1/4 to 1/4,194,304.
Plates were incubated for eight days at 28 o C, and read in an inverted microscope at 200x magnification. Dilutions were considered to be positive when at least one live parasite was observed. Counts were transformed into geometric means and used in the formula that determined parasite load (9).
Cytokine Quantification
IL-2, IFN-γ, IL-4 and IL-10 were quantified in the supernatant of total spleen cell cultures in 48-well plates containing 5 x 10 6 cells/mL stimulated or not with L.
chagasi-sonicated antigen (10 µg/mL). Cultures were incubated at 37 o C, in 5% CO 2 for 48 hours. The supernatant was maintained at -80°C until analyzed by Duoset® ELISA Development System according to the manufacturer's instructions (R&D Systems, USA).
Statistical Analysis
Variance analysis was used to assess differences in cytokine production; Student's t test was used to determine percentage differences of CD4 and CD8 cells and in parasite loads of spleen and liver; Tukey's test was used to determine spleen weight differences among the different groups (12) .
RESULTS
Although the study involved two trials, the results presented herein are based on the more representative one.
Spleen Weight
According to Figure 1 , mean spleen weight of immunosuppressed groups II and IV on day 0, (31.50 ± 4.87 and 27.00 ± 1.22 mg, respectively) was significantly lower than that of non-immunosuppressed groups I and III (119.00 ± 10.42 and 110.25 ± 4.09 mg, respectively) (p < 0.05). On day 3, mean spleen weight of Group III (nonimmunosuppressed and infected on day 0) was statistically greater than that of the other groups. On day 7, groups III and IV (immunosuppressed and infected, and only infected, respectively) were not statistically different from each other but presented greater mean spleen weight than those of the other two non-infected groups.
However, results of Group II (immunosuppressed and not infected) were significantly lower than those of the other groups. On days 14 and 21, Group II was not statistically different from the control group (I), but was different from the infected groups (III and IV) (p < 0.05). showed greater IFN-γ production on day 21 (Figure 2 -A) .
IL-10 concentration in immunosuppressed groups (II and IV) was statistically greater than in non-immunosuppressed groups (I and III) on days 3 and 7 (p < 0.05). This cytokine was also detected in the infected groups (III and IV). However, its production was greater on days 3 and 7 than on days 14 and 21 (Figure 2 -B) .
IL-2 concentration in immunosuppressed groups (II and IV) was statistically greater than in non-immunosuppressed groups (I and III) on day 7. In the infected, nonimmunosuppressed group (III), this cytokine was detected only on day 7, and in the immunosuppressed infected group (IV), production on day 21 was statistically greater than in all the other groups (p < 0.05) (Figure 2 -C).
Machado and IV -immunosuppressed until day 0 and infected on day 0) and by the day on which the animals were euthanized (3, 7, 14 and 21) .
DISCUSSION
Spleen weight in dexamethazone-immunosuppressed animals (groups II and IV) was statistically lower than in non-immunosuppressed animals (groups I and III). These results were similar to those by Lebrec et al. (13) and Keil et al. (14) , who observed a statistically significant, dose-dependent decrease in spleen weight after DXM administration. Miller and Schaefer (15) reported decreases in spleen and thymus size greater than 80% followed by increase in spleen size when DXM treatment was concluded, as occurred in the present study (Figure 1 ). This fact suggests either a partial recovery of spleen cells sensitive to DXM or a reversible immunosuppression model (16, 17) . Infected groups showed increased spleen weight, while However, according to Rousseau et al. (31) , these cells were able to respond to any specific antigen by producing IFN-γ in the chronic phase (70 days after infection).
In relation to cytokine production, IL-4 was absent both in non-stimulated and stimulated spleen cell cultures. According to Goto and Lindoso (32) , IL-4 is not involved in susceptibility to visceral leishmania, while this cytokine has been found by other authors to lack any significant role in murine models infected with this organism (21, 26, 30) .
Parasite loads in spleen and liver tissue of the infected groups (III and IV) were similar at the majority of observational moments. However, on day 3, loads in group IV (immunosuppressed) were greater than in group III (non-immunosuppressed), and were more evident in the spleen, but without any statistical difference (p < 0.05).
Group IV appeared to be still affected by DXM treatment, as corroborated by Rousseau et al. (16) , who observed an augmented parasite load increased during the chronic phase of L. infantum infection in spleen tissue of DXM-treated mice; and by Gangneux et al. (21) , who showed that mice treated with DXM and pentoxifiline showed significant increases in parasite loads in spleen and liver compared with the control group. In the present study, parasite loads in these two groups were similar at day 3 ( Figure 4 ).
Parasite loads in the liver of both infected groups were greater than in the spleen, at all moments, a finding similar to those of Rousseau et al. (31) and Honoré et al. (33) .
However, Rousseau et al. (31) showed that parasite load decreased in the liver, but increased in the spleen. Apparently, the liver is the focus for parasite multiplication while the spleen functions as a shelter for its prolonged persistency (34). Rolão et al. (27) suggested that the spleen was more susceptible to L. infantum infection than the liver.
The finding herein that spleen weight was lower in the immunosuppressed group than in the control and uninfected groups at the end of immunosuppressive treatment suggests that immunosuppression caused by dexamethasone until day 0 was reversible because by the end of treatment animals had apparently recovered from immunosuppression. Furthermore, at the last observation moment of the study, mean spleen weight of the immunosuppressed uninfected group was statistically similar to that of Group I (control group). Another parameter that demonstrates this possible reversible immunosuppression was cytokine production in non-stimulated cultures.
On days 3, 7, 14 and 21 after dexamethasone treatment ended, none of the cytokines evaluated (Th1 and Th2) showed decreased production in the immunosuppressed group (II) compared with the control group (I); instead, Th1 and Th2 production was increased. In the group immunosuppressed until day 0 then infected (Group IV), immunosuppression did not cause an exacerbation in L. chagasi infection because the parasite loads in this group and in the group that was only infected (III) did not differ statistically. It was concluded that L. chagasi infection was not affected by dexamethasone-induced immunosuppression, probably due the reversible effect of the treatment.
